Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
6,009,091
-
Shares change
-
-389,093
-
Total reported value, excl. options
-
$33,278,940
-
Value change
-
-$2,137,110
-
Number of buys
-
10
-
Number of sells
-
-15
-
Price
-
$5.55
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2017
36 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2017.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,009,091 shares
of 48,932,355 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include FMR LLC (1,516,212 shares), JPMORGAN CHASE & CO (1,459,117 shares), ROYCE & ASSOCIATES LP (881,000 shares), SPHERA FUNDS MANAGEMENT LTD. (501,000 shares), VANGUARD GROUP INC (419,922 shares), STIFEL FINANCIAL CORP (415,279 shares), MILLENNIUM MANAGEMENT LLC (170,058 shares), Opus Point Partners Management, LLC (133,500 shares), Allianz Asset Management GmbH (125,670 shares), and GEODE CAPITAL MANAGEMENT, LLC (94,205 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.